175 related articles for article (PubMed ID: 22673945)
21. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
[TBL] [Abstract][Full Text] [Related]
23. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
25. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
[TBL] [Abstract][Full Text] [Related]
26. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes.
Dai J; Gu J; Huang M; Eng C; Kopetz ES; Ellis LM; Hawk E; Wu X
Carcinogenesis; 2012 Jul; 33(7):1327-31. PubMed ID: 22505654
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
[TBL] [Abstract][Full Text] [Related]
28. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
29. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer.
Sakin A; Samanci NS; Secmeler S; Arici S; Can O; Yasar N; Geredeli C; Demir C; Cihan S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S176-S182. PubMed ID: 33380674
[TBL] [Abstract][Full Text] [Related]
30. Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.
Lenehan PF; Boardman LA; Riegert-Johnson D; De Petris G; Fry DW; Ohrnberger J; Heyman ER; Gerard B; Almal AA; Worzel WP
Cancer; 2012 Nov; 118(21):5234-44. PubMed ID: 22605513
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations in the HIF1A gene modulate response to adjuvant chemotherapy after surgery in patients with colorectal cancer.
Zhang Y; Wang P; Zhou XC; Bao GQ; Lyu ZM; Liu XN; Wan SG; He XL; Huang QC
Asian Pac J Cancer Prev; 2014; 15(11):4637-42. PubMed ID: 24969897
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in the Angiogenesis-Related Genes
Scherer D; Deutelmoser H; Balavarca Y; Toth R; Habermann N; Buck K; Kap EJ; Botma A; Seibold P; Jansen L; Lorenzo Bermejo J; Weigl K; Benner A; Hoffmeister M; Ulrich A; Brenner H; Burwinkel B; Chang-Claude J; Ulrich CM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751332
[TBL] [Abstract][Full Text] [Related]
33. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis.
Xing J; Myers RE; He X; Qu F; Zhou F; Ma X; Hyslop T; Bao G; Wan S; Yang H; Chen Z
Eur J Cancer; 2011 Jul; 47(11):1699-707. PubMed ID: 21402474
[TBL] [Abstract][Full Text] [Related]
34. Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Bohanes P; Yang D; Loupakis F; LaBonte MJ; Gerger A; Ning Y; Lenz C; Lenz F; Wakatsuki T; Zhang W; Benhaim L; El-Khoueiry A; El-Khoueiry R; Lenz HJ
Pharmacogenomics J; 2015 Jun; 15(3):226-34. PubMed ID: 25487679
[TBL] [Abstract][Full Text] [Related]
35. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy.
Yhim HY; Cho SH; Kim SY; Cho IS; Lee KT; Lee WS; Lee SI; Park MR; Park SG; Han HS; Choi YS; Chung IJ; Shim HJ; Lee NR; Song EK; Kim HS; Yim CY
Oncol Rep; 2015 Jul; 34(1):155-64. PubMed ID: 25955097
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer.
Xing J; Wan S; Zhou F; Qu F; Li B; Myers RE; Fu X; Palazzo JP; He X; Chen Z; Yang H
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):217-27. PubMed ID: 22028396
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
